EHMT2 and esophageal squamous cell carcinoma: Taken together, these data suggest that knocking down LSD1 and G9a increases the efficacy of UNC0642 and SP2509, respectively, at inducing death in ESCC cells, thus resembling the effects of pharmacologically inhibiting LSD1 and G9a.